Avience Biomedicals IPO Date, Review, Price, Allotment Details

Avience Biomedicals IPO is offering its shares to the public for the first time through an IPO on the stock exchanges NSE SME. The total amount they aim to raise is 14,53,800 shares (agg. up to ₹30 Cr). Out of this 13,71,600 shares (agg. up to ₹29 Cr) will be through new shares, and [.] through existing shares. The IPO is open for subscription from 18 June, 2026 to 22 June, 2026. Each share has a face value of Rs 10, and investors can apply for shares at a price between ₹196 to ₹208 per share. The minimum number of shares one can apply for is 600, or multiples of that as mentioned in the offer document.
  Check Live IPO GMP List  👈
  Check Live IPO  Subscription List  👈
  Check All IPO  Allotment List  👈
Upcoming

Avience Biomedicals IPO Details

IPO Category Type: SME
IPO Open: 18 June, 2026
IPO Close: 22 June, 2026
IPO Price Band: ₹196 to ₹208 per share
Face Value: ₹10 Per Equity Share
IPO Listing on: NSE SME
IPO Issue Type: Book Build Issue
IPO Size: Approx 14,53,800 shares (agg. up to ₹30 Cr)
Fresh Issue: Approx 13,71,600 shares (agg. up to ₹29 Cr)
Offer for Sale: Approx [.]

Avience Biomedicals IPO Reservation

Retail Quota: 33.10%
QIB Quota: 47.01%
NII Quota: 14.24%
Employee Discount: [.]

Avience Biomedicals IPO Prospectus

DRHP Draft Prospectus: [.]
RHP Draft Prospectus: [.]
Anchor Investors List: [.]

Avience Biomedicals IPO Market Lot Details

Application Lot Size Shares Amount
1 600 ₹124800
Application Lot Size Shares Amount
Individual investors (IND) (Min) 2 1,200 249600
Individual investors (IND) (Max) 2 1,200 249600
S-HNI (Min) 3 1,800 374400
S-HNI (Max) 8 4,800 998400
B-HNI (Min) 9 5,400 1123200

Avience Biomedicals IPO Dates

IPO Activity Date
Open Date: 18 June, 2026
Close Date: 22 June, 2026
Allotment Date: 23 June, 2026
Refund Date: 24 June, 2026
Shares Credit Date: 24 June, 2026
Listing Date: 25 June, 2026

Avience Biomedicals Company Financial Report

Period Ended 31 Jan 2026 31 Mar 2025 31 Mar 2024
Assets 66.07 56.52 34.65
Total Income 41.94 45.97 24.37
Profit After Tax 5.74 7.23 2.14
EBITDA 10.34 11.41 4.08
NET Worth 28.52 22.78 6.21
Reserves and Surplus 24.49 18.75 2.93
Total Borrowing 26.73 22.16 15.13
Amount in ₹ Crore

Avience Biomedicals Company Address

Company Avience Biomedicals Ltd.
Address Delhi, New Delhi, 110058
Phone 1800-12-04-636
Email info@avienbio.com
Website https://avienbio.com/

Avience Biomedicals IPO Registrar

Company Skyline Financial Services Pvt.Ltd.
Phone 02228511022
Email ipo@skylinerta.com
Website https://www.skylinerta.com/ipo.php

Avience Biomedicals IPO Lead Manager

  • Fintellectual Corporate Advisors Pvt.Ltd.

Avience Biomedicals IPO KPI

KPI Values
ROE 22.38%
ROCE 16.99%
Debt/Equity 0.94
RoNW 22.38%
EBITDA Margin 24.70%
Price to Book Value 2.94

Avience Biomedicals IPO - FAQs

Q.What is Avience Biomedicals IPO?

Ans.Avience Biomedicals IPO is a SME IPO. The IPO is list on NSE SME. The total amount Avience Biomedicals aim to raise is 14,53,800 shares (agg. up to ₹30 Cr).


Q.When Avience Biomedicals IPO will open?

Ans.Avience Biomedicals IPO is to open on 18 June, 2026 for Investors.


Q.What is Avience Biomedicals IPO Investors Portion?

Ans.Avience Biomedicals investor's portion for QIB is 47.01%, NII is 14.24%, and Retail is 33.10%.


Q.What is Avience Biomedicals IPO Size?

Ans.Avience Biomedicals IPO size is 14,53,800 shares (agg. up to ₹30 Cr).


Q.What is Avience Biomedicals IPO Price Band?

Ans.Avience Biomedicals IPO Price Band is ₹196 to ₹208 per share.


Q.What is the Avience Biomedicals IPO Allotment Date?

Ans.Avience Biomedicals IPO allotment date is 23 June, 2026.


Q.What is the Avience Biomedicals IPO Listing Date?

Ans.Avience Biomedicals IPO listing date is 25 June, 2026. The IPO is to list on NSE SME.